PMV Pharmaceuticals, Inc. (PMVP)

NASDAQ: PMVP · IEX Real-Time Price · USD

1.560

-0.030 (-1.89%)

At close: Jul 19, 2024, 4:00 PM

1.620

+0.060 (3.85%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

PMV Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Selling, General & Admin	22.88	24.25	25.05	21.8	11.01	5.88	Upgrade
Research & Development	54	55.89	51.99	36.49	23.93	20.76	Upgrade
Operating Expenses	76.87	80.13	77.04	58.29	34.94	26.64	Upgrade
Operating Income	-76.87	-80.13	-77.04	-58.29	-34.94	-26.64	Upgrade
Other Expense / Income	-11.77	-11.17	-3.71	-0.47	-0.51	-1.29	Upgrade
Pretax Income	-65.1	-68.96	-73.33	-57.82	-34.43	-25.34	Upgrade
Income Tax	0	0	-0.01	0.02	0.01	0.01	Upgrade
Net Income	-65.1	-68.96	-73.32	-57.85	-34.44	-25.35	Upgrade
Shares Outstanding (Basic)	51	48	46	45	14	3	Upgrade
Shares Outstanding (Diluted)	51	48	46	45	14	3	Upgrade
Shares Change	12.39%	5.31%	1.01%	214.23%	373.26%	0.76%	Upgrade
EPS (Basic)	-1.33	-1.44	-1.61	-1.28	-2.40	-8.35	Upgrade
EPS (Diluted)	-1.33	-1.44	-1.61	-1.28	-2.40	-8.35	Upgrade
Free Cash Flow	-58.23	-56.62	-71.74	-47.92	-32.89	-22.17	Upgrade
Free Cash Flow Per Share	-1.13	-1.18	-1.57	-1.06	-2.29	-7.31	Upgrade
EBITDA	-64.02	-68.07	-72.68	-56.54	-34.12	-24.96	Upgrade
Depreciation & Amortization	1.08	0.89	0.65	1.28	0.32	0.39	Upgrade
EBIT	-65.1	-68.96	-73.33	-57.82	-34.43	-25.34	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).